Empirical Study on Lifestyle Intervention for Elderly Hypertensive Patients in Community Based on TTM Theory

This study intervention is based on TTM theory and implements lifestyle interventions, including nutritious diet, regular exercise, social support, sleep optimization, avoidance of addictive substances, and stress management. Through various means such as training, guidance, and motivation, motivation is formed, goals are determined, and habits are strengthened, ultimately leading to the development of a healthy lifestyle, control of blood pressure indicators, and improvement of quality of life and cognitive function. The intervention period is a total of 3 weeks, on line.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Hypertension (HTN) Age More 60yr Cardiovascular Diseases Hypertension Vascular Diseases

Age range

60 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients whose blood pressure measurements taken at community hospitals meet the hypertension criteria outlined in the Chinese Guidelines for the Prevention and Treatment of Hypertension (2024 revision);
Aged 60-75 years old;
Have certain abilities in reading, comprehension, and communication;
Able to use a smartphone;
In the pre-conscious/conscious/preparatory stage.
Volunteer to participate in this study and sign the informed consent form.

Exclusion criteria

Exclude those with a history of severe heart, brain, kidney diseases or cancer;
Patients who currently have or have previously had mental disorders;
Patients who are currently participating in other research projects.

Treatment and study plan

Lifestyle Medicine

Behavioral

Lifestyle medicine includes Nutrition , Physical Activity , Stress Management, Restorative Sleep , Social Connectedness, Avoidance of Risky Substances .

Primary outcomes

blood pressure

Time frame: Baseline, the end of treatment at 3 weeks, and after 3 months
Patient quality of life (SF-36)

Time frame: Baseline, the end of treatment at 3 weeks, and after 3 months

Secondary outcomes

Patient cognitive function (AD8)

Time frame: Baseline, the end of treatment at 3 weeks, and after 3 months
Patients' lifestyle (HPLP Ⅱ)

Time frame: Baseline, the end of treatment at 3 weeks, and after 3 months

Study contacts

Contact information is provided by the study sponsor or research team.

Lu Zhang

CONTACT

[email protected]

+8618750236498

Sponsors and collaborators

Lead sponsor

Qu Shen

Other

Registry information

Important dates

Study start: 2026
Primary completion: 2026
Study completion: 2026
First posted: Mar 25, 2026
Registry last updated: Mar 25, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Not Yet Recruiting